CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
106 hedge funds and large institutions have $3.82B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 13 closing their positions.
Holders
106
Holders Change
+12
Holders Change %
+12.77%
% of All Funds
1.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
43
Reduced
27
Closed
13
Calls
$17M
Puts
$4.33M
Net Calls
+$12.7M
Net Calls Change
+$613K
Top Buyers
| 1 |
1
Lord, Abbett & Co
Jersey City,
New Jersey
|
$23.6M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$633M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$6.85M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$195M |
| 5 |
5
BlackRock
New York
|
$113M |
Top Sellers
| 1 |
1
Alkeon Capital Management
New York
|
$61.9M |
| 2 |
2
Alyeska Investment Group
Chicago,
Illinois
|
$0 |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$575K |
| 4 |
AG
4
Artal Group
Luxembourg
|
$48.6M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$11.1M |